Royal Bank of Canada »

Impact Biomedical shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 1 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Impact Biomedical

BlackRock
Vanguard Group
Geode Capital Management
Two Sigma Investments
Two Sigma Securities
Susquehanna International
UBS Group
State Street Corporation
Mason & Associates
Tower Research Capital
Wells Fargo & Company
Newbridge Financial Services Group
FMR
CWM
Signature Resources Capital Management

View all funds holding Impact Biomedical